KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $2.2 billion.

  • Gilead Sciences' Net Cash Flow fell 126.13% to $2.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 billion, marking a year-over-year increase of 41373.09%. This contributed to the annual value of $3.9 billion for FY2024, which is 54058.44% up from last year.
  • Per Gilead Sciences' latest filing, its Net Cash Flow stood at $2.2 billion for Q3 2025, which was down 126.13% from -$2.9 billion recorded in Q2 2025.
  • Over the past 5 years, Gilead Sciences' Net Cash Flow peaked at $5.0 billion during Q4 2024, and registered a low of -$2.9 billion during Q2 2025.
  • For the 5-year period, Gilead Sciences' Net Cash Flow averaged around $69.8 million, with its median value being $32.0 million (2022).
  • Data for Gilead Sciences' Net Cash Flow shows a peak YoY increase of 3161428.57% (in 2024) and a maximum YoY decrease of 35663.13% (in 2024) over the last 5 years.
  • Gilead Sciences' Net Cash Flow (Quarter) stood at $985.0 million in 2021, then tumbled by 35.23% to $638.0 million in 2022, then crashed by 46.24% to $343.0 million in 2023, then skyrocketed by 1360.64% to $5.0 billion in 2024, then plummeted by 56.25% to $2.2 billion in 2025.
  • Its Net Cash Flow stands at $2.2 billion for Q3 2025, versus -$2.9 billion for Q2 2025 and -$2.1 billion for Q1 2025.